Form 4: SXI awards 639 restricted shares; three-year vesting
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Standex International (SXI): A company director reported a grant of 639 restricted shares of common stock on 10/21/2025 at $0 under the company’s 2018 Omnibus Incentive Plan. The award is scheduled to vest three years after the grant date.
Following this transaction, the director’s beneficial ownership stands at 12,905.4464 shares, held directly. This filing records an equity compensation award and does not indicate any open‑market purchase or sale.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
Hickey Michael A
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 639 | $0.00 | -- |
Holdings After Transaction:
Common Stock — 12,905.446 shares (Direct)
Footnotes (1)
- [object Object]
FAQ
What did Standex International (SXI) disclose in this Form 4?
A director received a grant of 639 restricted shares on 10/21/2025 at $0 under the 2018 Omnibus Incentive Plan.
What is the vesting schedule for the restricted stock grant at SXI?
The award vests three years after the date of grant.
Was this an open-market buy or sell of SXI stock?
No. It was a restricted stock grant reported at $0 price, not a market transaction.
What is the reporting person’s relationship to SXI?
The reporting person is a Director of Standex International.